Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01257542 · ClinicalTrials.gov registry record · Phase 4
Acute Cough Study In Children
A Phase 4 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
NCT01257542 is a Phase 4 study that was terminated before completion, run by Pfizer. The registered enrollment target is 140 participants.
The verdict
NCT01257542, a Phase 4 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
Study Summary
15 mg dextromethorphan hydrobromide will be better than placebo with respect to reducing the number of coughs over 6 hours and reducing the subjective severity of cough over 6 hours.
Interventions
- DRUG Placebo
- DRUG Dextromethorphan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01257542
The ClinicalTrials.gov registry entry for NCT01257542 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01257542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01257542 about?
NCT01257542 is a clinical study titled "Acute Cough Study In Children". 15 mg dextromethorphan hydrobromide will be better than placebo with respect to reducing the number of coughs over 6 hours and reducing the subjective severity of cough over 6 hours.
What is the current status of trial NCT01257542?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2010-12. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01257542?
The interventions under investigation include: Placebo (DRUG), Dextromethorphan (DRUG).
Who is sponsoring clinical trial NCT01257542?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.